المؤلفون: Vandtved, Julie Haugaard, Øvlisen, Andreas Kiesbye, Baech, Joachim, Weinrich, Ulla Møller, Severinsen, Marianne Tang, Maksten, Eva Futtrup, Jakobsen, Lasse Hjort, Glimelius, Ingrid, Kamper, Peter, Hutchings, Martin, Specht, Lena, Dahl-Sørensen, Rasmus, Christensen, Jacob Haaber, El-Galaly, Tarec C.

المصدر: Vandtved , J H , Øvlisen , A K , Baech , J , Weinrich , U M , Severinsen , M T , Maksten , E F , Jakobsen , L H , Glimelius , I , Kamper , P , Hutchings , M , Specht , L , Dahl-Sørensen , R , Christensen , J H & El-Galaly , T C 2024 , ' Pulmonary diseases in patients with classical Hodgkin lymphoma relative to a matched background population : A Danish national cohort study ' , British Journal of Haematology , vol. 205 , no. 2 , ....

مصطلحات موضوعية: bleomycin, hodgkin lymphoma, late effects, obstructive lung diseases, pulmonary diseases, pulmonary fibrosis, Lung Diseases/chemically induced, Doxorubicin/adverse effects, Procarbazine/adverse effects, Humans, Middle Aged, Male, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Incidence, Young Adult, Hodgkin Disease/epidemiology, Female, Adult, Denmark/epidemiology, Adolescent, Aged, Vincristine/adverse effects, Cyclophosphamide/adverse effects, Bleomycin/adverse effects, Cohort Studies

وصف الملف: application/pdf

Relation: https://portal.findresearcher.sdu.dk/da/publications/6f09b6bc-ccf6-4b8b-bd5b-9fec6d58e515

الاتاحة: https://portal.findresearcher.sdu.dk/da/publications/6f09b6bc-ccf6-4b8b-bd5b-9fec6d58e515
https://doi.org/10.1111/bjh.19475
https://findresearcher.sdu.dk/ws/files/269657338/Br_J_Haematol_-_2024_-_Vandtved_-_Pulmonary_diseases_in_patients_with_classical_Hodgkin_lymphoma_relative_to_a_matched.pdf

المؤلفون: Corvest, Victoria, Marec-Bérard, Perrine, Lervat, Cyril, Pacquement, Hélène D., Toulmonde, Maud, Gentet, Jean Claude, Laurence, Valérie, Cleirec, Morgane, Mansuy, Ludovic, Bompas, Emmanuelle, Castex, Marie Pierre, Taque, Sophie, Filhon, Bruno, Tabone, Marie Dominique P., Verité, Cécile, Entz-Werle, Natacha, Saumet, Laure, Guimard, Grégory, Pondrom, Morgane, Chevreau, Christine, Flandrin, Jennifer, Duranteau, Lise, Rousset-Jablonski, Christine Md Phd, Brugières, Laurence, Jimenez, Marta M., Le Deley, Marie Cécile Cécile, Gaspar, Nathalie, Fresneau, Brice C.

المساهمون: Institut Gustave Roussy (IGR), Centre Léon Bérard Lyon, Institut d'hématologie et d'oncologie pédiatrique CHU - HCL (IHOPe), Hospices Civils de Lyon (HCL), Centre Régional de Lutte contre le Cancer Oscar Lambret Lille (UNICANCER/Lille), Université de Lille-UNICANCER, Institut Curie Paris, Institut Bergonié Bordeaux, UNICANCER, Hôpital de la Timone CHU - APHM (TIMONE), Centre Hospitalier Universitaire de Nantes = Nantes University Hospital (CHU Nantes), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), CRLCC René Gauducheau, Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Centre Hospitalier Universitaire de Rennes CHU Rennes = Rennes University Hospital Ponchaillou, CHU Rouen, Normandie Université (NU), CHU Trousseau APHP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Sorbonne Université (SU), Hôpital Pellegrin, CHU Bordeaux-Groupe hospitalier Pellegrin, Centre Hospitalier Universitaire Strasbourg (CHU Strasbourg), Les Hôpitaux Universitaires de Strasbourg (HUS), Hôpital Arnaud de Villeneuve CHRU Montpellier, Centre Hospitalier Régional Universitaire Montpellier (CHRU Montpellier), Hôpital universitaire Robert Debré Reims (CHU Reims), Centre Hospitalier Universitaire de Nice (CHU Nice), Institut Claudius Regaud, Pôle IUCT CHU Toulouse, Hôpital Bicêtre AP-HP, Le Kremlin-Bicêtre, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Research on Healthcare Performance (RESHAPE - Inserm U1290 - UCBL1), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre de recherche en épidémiologie et santé des populations (CESP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay, Institut Gustave-Roussy, Centre Léon Bérard, CLB, Thanks to the investigators of the following French centers which contributed patients to our study: Centre Léon Bérard, medical oncology, Lyon, CHU St Etienne, CHU Clermont Ferrand, CHU Amiens, Regional Cancer Center, Nancy, Regional Cancer Center, Caen, CHU Besançon, Institut Gustave-Roussy, medical oncology, Villejuif, CHU Tours, CHU Marseille, CHU Grenoble, Regional Cancer Center, Dijon, Regional Cancer Center, Clermont Ferrand, Lenval Hospital, Nice, Regional Cancer Center, Angers, CHU Rouen.

المصدر: ISSN: 0020-7136.

مصطلحات موضوعية: antineoplastic combined chemotherapy protocols/adverse effects, child, cyclophosphamide/adverse effects, Ewing/drug therapy, Ifosfamide/adverse effects, [SDV.CAN]Life Sciences [q-bio]/Cancer

Relation: info:eu-repo/semantics/altIdentifier/pmid/36250317; hal-04122360; https://hal.science/hal-04122360; https://hal.science/hal-04122360/document; https://hal.science/hal-04122360/file/IJC-152-1659.pdf; PUBMED: 36250317; PUBMEDCENTRAL: PMC10092329

الاتاحة: https://hal.science/hal-04122360
https://hal.science/hal-04122360/document
https://hal.science/hal-04122360/file/IJC-152-1659.pdf
https://doi.org/10.1002/ijc.34326

المؤلفون: de Boo, Leonora W., Jóźwiak, Katarzyna, Joensuu, Heikki, Lindman, Henrik, Lauttia, Susanna, Opdam, Mark, van Steenis, Charlaine, Brugman, Wim, Kluin, Roelof J.C., Schouten, Philip C., Kok, Marleen, Nederlof, Petra M., Hauptmann, Michael, Linn, Sabine C.

المساهمون: Medisch Oncologische Disciplines, Pathologie, Cancer

مصطلحات موضوعية: Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Breast Neoplasms/drug therapy, Capecitabine/therapeutic use, Chemotherapy, Adjuvant, Cyclophosphamide/adverse effects, Disease-Free Survival, Docetaxel/therapeutic use, Epirubicin/adverse effects, Female, Homologous Recombination, Humans, Triple Negative Breast Neoplasms/drug therapy, Oncology, Cancer Research, Research Support, Non-U.S. Gov't, Randomized Controlled Trial, Journal Article

وصف الملف: application/pdf

Relation: https://dspace.library.uu.nl/handle/1874/447374

الاتاحة: https://dspace.library.uu.nl/handle/1874/447374

المؤلفون: Savage, Kerry J, Horwitz, Steven M, Advani, Ranjana, Christensen, Jacob Haaber, Domingo-Domenech, Eva, Rossi, Giuseppe, Morschhauser, Franck, Alpdogan, Onder, Suh, Cheolwon, Tobinai, Kensei, Shustov, Andrei, Trneny, Marek, Yuen, Sam L S, Zinzani, Pier Luigi, Truemper, Lorenz H, Illidge, Tim M, O'Connor, Owen A, Pro, Barbara, Miao, Harry, Bunn, Veronica, Fenton, Keenan, Fanale, Michelle, Puhlmann, Markus, Iyer, Swaminathan P

المصدر: Savage , K J , Horwitz , S M , Advani , R , Christensen , J H , Domingo-Domenech , E , Rossi , G , Morschhauser , F , Alpdogan , O , Suh , C , Tobinai , K , Shustov , A , Trneny , M , Yuen , S L S , Zinzani , P L , Truemper , L H , Illidge , T M , O'Connor , O A , Pro , B , Miao , H , Bunn , V , Fenton , K , Fanale , M , Puhlmann , ....

مصطلحات موضوعية: Brentuximab Vedotin, Cyclophosphamide/adverse effects, Doxorubicin/adverse effects, Hematopoietic Stem Cell Transplantation, Humans, Ki-1 Antigen, Lymphoma, Large-Cell, Anaplastic/chemically induced, Neoplasm Recurrence, Local, Prednisone/adverse effects, Vincristine/adverse effects

وصف الملف: application/pdf

الاتاحة: https://portal.findresearcher.sdu.dk/da/publications/5ce81efd-48d0-4643-94b5-e66402b7aaec
https://doi.org/10.1182/bloodadvances.2020003971
https://findresearcher.sdu.dk/ws/files/211815051/Open_Access_Version.pdf

المؤلفون: Souza, Cláudio Antônio de, Simões, Ricardo, Borges, Karina Braga Gomes, Oliveira, Angélica Navarro de, Zogeib, Juliana Barroso, Alves, Bruno, Malachias, Marcus Vinicius Bolívar, Drummond-Lage, Ana Paula, Rezende, Bruno Almeida

المصدر: Arquivos Brasileiros de Cardiologia. November 2018 111(5)

مصطلحات موضوعية: Breast Neoplasms, Vascular Stiffness, Stroke Volume/drug effects, Cardiotoxicity, Doxorubicin/adverse effects, Cyclophosphamide/adverse effects

وصف الملف: text/html

URL الوصول: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2018001700721

المؤلفون: Steinhardt, Maximilian Johannes, Krummenast, Franziska C., Rosenwald, Andreas, Gerhard-Hartmann, Elena, Heidemeier, Anke, Einsele, Hermann, Topp, Max S., Duell, Johannes

المصدر: http://lobid.org/resources/99370674181806441#!, 148(1):205-214.

مصطلحات موضوعية: HD, Lymphoma, Aged [MeSH], Prednisone/adverse effects [MeSH], Original Article – Clinical Oncology, Cytarabine/therapeutic use [MeSH], Progression-Free Survival [MeSH], Cyclophosphamide/therapeutic use [MeSH], Cyclophosphamide/adverse effects [MeSH], Rituximab/therapeutic use [MeSH], Male [MeSH], Central Nervous System Neoplasms/drug therapy [MeSH], Prednisone/therapeutic use [MeSH], Female [MeSH], Carmustine/therapeutic use [MeSH], Doxorubicin/adverse effects [MeSH], Large B-Cell, Diffuse/drug therapy [MeSH], Adult [MeSH], R-CHOP, Humans [MeSH], Hematopoietic Stem Cell Transplantation [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH], MTX, Antineoplastic Combined Chemotherapy Protocols/adverse effects [MeSH], Vincristine/therapeutic use [MeSH], Methotrexate/therapeutic use [MeSH], Doxorubicin/therapeutic use [MeSH]

Relation: https://repository.publisso.de/resource/frl:6449866; https://doi.org/10.1007/s00432-021-03663-x; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752544/

الاتاحة: https://repository.publisso.de/resource/frl:6449866
https://doi.org/10.1007/s00432-021-03663-x
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752544/

المساهمون: Yu Ri Kim, Soo-Jeong Kim, Yong Park, Sung Yong Oh, Hwan-Jung Yun, Yeung-Chul Mun, Jin Seok Kim, Kim, Yu Ri

مصطلحات موضوعية: Aged, Antineoplastic Combined Chemotherapy Protocols* / adverse effects, Cyclophosphamide / adverse effects, Doxorubicin / adverse effects, Female, Granulocyte Colony-Stimulating Factor / therapeutic use, Humans, Lymphoma, Non-Hodgkin* / drug therapy, Middle Aged, Prednisone / adverse effects, Retrospective Studies, Risk Factors, Vincristine / adverse effects, Albumin, Elderly, Febrile neutropenia, non-Hodgkin

Relation: KOREAN JOURNAL OF INTERNAL MEDICINE; J02883; OAK-2021-05829; https://ir.ymlib.yonsei.ac.kr/handle/22282913/185107; T202104004; KOREAN JOURNAL OF INTERNAL MEDICINE, Vol.36(5) : 1181-1189, 2021-09

الاتاحة: https://ir.ymlib.yonsei.ac.kr/handle/22282913/185107
https://doi.org/10.3904/kjim.2020.206

المؤلفون: Seydoux, Claire, Medinger, Michael, Gerull, Sabine, Halter, Joerg, Heim, Dominik, Chalandon, Yves, Masouridi Levrat, Stavroula, Schanz, Urs, Nair, Gayathri, Ansari Djaberi, Marc Georges, Simon, Patrick, Passweg, Jakob R, Cantoni, Nathan

المصدر: ISSN: 0939-5555 ; Annals of hematology, vol. 100, no. 1 (2021) p. 209-216.

مصطلحات موضوعية: info:eu-repo/classification/ddc/616, info:eu-repo/classification/ddc/618, Busulfan, Conditioning regimen, Cyclophosphamide, Hematopoietic cell transplantation, Liver toxicity, Adult, Aged, Busulfan / administration & dosage, Busulfan / adverse effects, Chemical and Drug Induced Liver Injury / diagnosis, Chemical and Drug Induced Liver Injury / mortality, Cyclophosphamide / administration & dosage, Cyclophosphamide / adverse effects, Drug Therapy, Combination, Female, Hematologic Neoplasms / drug therapy, Hematologic Neoplasms / mortality, Hematologic Neoplasms / therapy, Hematopoietic Stem Cell Transplantation / methods, Hematopoietic Stem Cell Transplantation / mortality, Humans, Immunosuppressive Agents / administration & dosage, Immunosuppressive Agents / adverse effects, Male, Middle Aged, Prospective Studies, Transplantation Conditioning / methods

Relation: info:eu-repo/semantics/altIdentifier/pmid/33098041; https://archive-ouverte.unige.ch/unige:156703; unige:156703

الاتاحة: https://archive-ouverte.unige.ch/unige:156703

المؤلفون: Speer, Claudius, Altenmüller-Walther, Christine, Splitthoff, Jan, Nusshag, Christian, Kälble, Florian, Reichel, Paula, Morath, Christian, Zeier, Martin, Bergner, Raoul, Schaier, Matthias

المصدر: http://lobid.org/resources/99370674188806441#!, 41(2):431-438.

مصطلحات موضوعية: Dose-Response Relationship, Drug [MeSH], Immunosuppressive Agents/administration, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/drug therapy [MeSH], Adverse effects, Humans [MeSH], Observational Research, Pneumonia/chemically induced [MeSH], Retrospective Studies [MeSH], Cyclophosphamide/adverse effects [MeSH], Cyclophosphamide/administration, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/mortality [MeSH], Recurrence [MeSH], Glucocorticoids, Disease-Free Survival [MeSH], Drug Therapy, Combination/adverse effects [MeSH], Remission Induction [MeSH], Sepsis/chemically induced [MeSH], Glucocorticoids/administration, Glucocorticoids/adverse effects [MeSH], Immunosuppressive Agents/adverse effects [MeSH], ANCA-associated vasculitis

Relation: https://repository.publisso.de/resource/frl:6469218; https://doi.org/10.1007/s00296-020-04752-9; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835159/

الاتاحة: https://repository.publisso.de/resource/frl:6469218
https://doi.org/10.1007/s00296-020-04752-9
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835159/

المؤلفون: Zettl, Florian, Ziepert, Marita, Altmann, Bettina, Zeynalova, Samira, Held, Gerhard, Pöschel, Viola, Hohloch, Karin, Wulf, Gerald G., Glass, Bertram, Schmitz, Norbert, Loeffler, Markus, Trümper, Lorenz

المصدر: http://lobid.org/resources/99370678538206441#!, 100(4):1031-1038.

مصطلحات موضوعية: Age Factors [MeSH], Aged, 80 and over [MeSH], Lymphoma, B-Cell/drug therapy [MeSH], Aged [MeSH], Aggressive lymphoma, Prednisone/adverse effects [MeSH], Multicenter Studies as Topic/statistics, Progression-Free Survival [MeSH], Clinical Trials, Phase II as Topic/statistics, Cyclophosphamide/adverse effects [MeSH], Diffuse large cell lymphoma, Feasibility Studies [MeSH], Rituximab/administration, Cyclophosphamide/administration, Original Article, Phase III as Topic/statistics, Male [MeSH], Rituximab/adverse effects [MeSH], Doxorubicin/administration, Randomized Controlled Trials as Topic/statistics, Elderly patients, Vincristine/administration, Dose-Response Relationship, Drug [MeSH], Antibiotic Prophylaxis [MeSH], Female [MeSH], Doxorubicin/adverse effects [MeSH]

Relation: https://repository.publisso.de/resource/frl:6467030; https://doi.org/10.1007/s00277-020-04345-3; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7960591/

الاتاحة: https://repository.publisso.de/resource/frl:6467030
https://doi.org/10.1007/s00277-020-04345-3
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7960591/

المساهمون: Ho Sup Lee, Kihyun Kim, Seok Jin Kim, Je-Jung Lee, Inho Kim, Jin Seok Kim, Hyeon-Seok Eom, Dok Hyun Yoon, Cheolwon Suh, Ho-Jin Shin, Yeung-Chul Mun, Min Kyoung Kim, Sung-Nam Lim, Chul Won Choi, Hye Jin Kang, Sung-Soo Yoon, Chang-Ki Min, Kim, Jin Seok

مصطلحات موضوعية: Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols / adverse effects, Antineoplastic Combined Chemotherapy Protocols / therapeutic use, Bortezomib / administration & dosage, Cyclophosphamide / administration & dosage, Cyclophosphamide / adverse effects, Dexamethasone / administration & dosage, Dexamethasone / adverse effects, Drug Resistance, Neoplasm, Febrile Neutropenia / epidemiology, Febrile Neutropenia / etiology, Female, Frail Elderly, Frailty / complications, Frailty / diagnosis, Hematologic Diseases / chemically induced, Hematologic Diseases / epidemiology, Humans, Incidence, Infections / epidemiology, Kaplan-Meier Estimate, Lenalidomide / administration & dosage, Male, Melphalan / administration & dosage, Middle Aged, Multiple Myeloma / drug therapy, Multiple Myeloma / genetics, Myeloma Proteins / analysis

Relation: AMERICAN JOURNAL OF HEMATOLOGY; J00085; OAK-2022-03777; https://ir.ymlib.yonsei.ac.kr/handle/22282913/190136; T9992020361; AMERICAN JOURNAL OF HEMATOLOGY, Vol.95(4) : 413-421, 2020-04

الاتاحة: https://ir.ymlib.yonsei.ac.kr/handle/22282913/190136
https://doi.org/10.1002/ajh.25726

المساهمون: Elizabeth A Mittendorf, Hong Zhang, Carlos H Barrios, Shigehira Saji, Kyung Hae Jung, Roberto Hegg, Andreas Koehler, Joohyuk Sohn, Hiroji Iwata, Melinda L Telli, Cristiano Ferrario, Kevin Punie, Frédérique Penault-Llorca, Shilpen Patel, Anh Nguyen Duc, Mario Liste-Hermoso, Vidya Maiya, Luciana Molinero, Stephen Y Chui, Nadia Harbeck, Sohn, Joo Hyuk

مصطلحات موضوعية: Adult, Albumins / administration & dosage, Antibodies, Monoclonal, Humanized / administration & dosage, Humanized / adverse effects, Antineoplastic Agents / administration & dosage, Antineoplastic Agents / adverse effects, Antineoplastic Combined Chemotherapy Protocols / administration & dosage, Antineoplastic Combined Chemotherapy Protocols / adverse effects, Cyclophosphamide / administration & dosage, Cyclophosphamide / adverse effects, Double-Blind Method, Doxorubicin / administration & dosage, Doxorubicin / adverse effects, Female, Humans, Middle Aged, Neoadjuvant Therapy, Paclitaxel / administration & dosage, Triple Negative Breast Neoplasms / drug therapy

Relation: LANCET; J02152; OAK-2021-05602; https://ir.ymlib.yonsei.ac.kr/handle/22282913/184907; https://www.sciencedirect.com/science/article/pii/S014067362031953X; T999202086; LANCET, Vol.396(10257) : 1090-1100, 2020-10

الاتاحة: https://ir.ymlib.yonsei.ac.kr/handle/22282913/184907
https://doi.org/10.1016/S0140-6736(20)31953-X
https://www.sciencedirect.com/science/article/pii/S014067362031953X

المؤلفون: Wilson, Matthew R., Eyre, Toby A., Martinez-Calle, Nicolas, Ahearne, Matthew, Parsons, Katrina E., Preston, Gavin, Khwaja, Jahanzaib, Schofield, Jeremy, Elliot, Johnathon, Kh, Almurtadha Mula, Shah, Nimish, Cheung, Cheuk Kie, Timmins, Matthew A., Creasey, Thomas, Linton, Kim, Smith, Jeffery, Fox, Christopher P., Miall, Fiona, Cwynarski, Kate, McKay, Pamela

المصدر: Wilson , M R , Eyre , T A , Martinez-Calle , N , Ahearne , M , Parsons , K E , Preston , G , Khwaja , J , Schofield , J , Elliot , J , Kh , A M , Shah , N , Cheung , C K , Timmins , M A , Creasey , T , Linton , K , Smith , J , Fox , C P , Miall , F , Cwynarski , K & McKay , P 2020 , ' Timing of high-dose methotrexate CNS prophylaxis in DLBCL : An ....

مصطلحات موضوعية: Antineoplastic Combined Chemotherapy Protocols/adverse effects, Central Nervous System Neoplasms/drug therapy, Cyclophosphamide/adverse effects, Doxorubicin/adverse effects, Humans, Lymphoma, Large B-Cell, Diffuse/drug therapy, Methotrexate/adverse effects, Neoplasm Recurrence, Local/drug therapy, Retrospective Studies, Rituximab/adverse effects, Vincristine/adverse effects, ResearchInstitutes_Networks_Beacons/mcrc, name=Manchester Cancer Research Centre

Relation: https://research.manchester.ac.uk/en/publications/0ffda5d1-ffa5-44ed-a85e-5343bb172871

الاتاحة: https://research.manchester.ac.uk/en/publications/0ffda5d1-ffa5-44ed-a85e-5343bb172871
https://doi.org/10.1182/bloodadvances.2020002421
http://www.scopus.com/inward/record.url?scp=85090598616&partnerID=8YFLogxK

المؤلفون: Booth, Stephen, Plaschkes, Hannah, Kirkwood, Amy A, Gibb, Adam, Horgan, Patrick, Higham, Claire, Oladipo, Joanna M, Browning, Joe, Khan, Usman, Tseu, Bing, Chen, Lucia, Willan, John, Wolf, Julia, Gunawan, Arief, Fields, Paul, Ebsworth, Tim, Lown, Robert, Gordon-Walker, Dominic, Shah, Nimish, Linton, Kim M, Collins, Graham P, Kothari, Jaimal, Hildyard, Catherine, Eyre, Toby A

المصدر: Booth , S , Plaschkes , H , Kirkwood , A A , Gibb , A , Horgan , P , Higham , C , Oladipo , J M , Browning , J , Khan , U , Tseu , B , Chen , L , Willan , J , Wolf , J , Gunawan , A , Fields , P , Ebsworth , T , Lown , R , Gordon-Walker , D , Shah , N , Linton , K M , Collins , G P , Kothari , J , Hildyard , C & Eyre , T ....

مصطلحات موضوعية: Aged, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Cyclophosphamide/adverse effects, Doxorubicin/adverse effects, Humans, Lymphoma, Large B-Cell, Diffuse/drug therapy, Retrospective Studies, Rituximab/adverse effects, Vincristine/adverse effects, ResearchInstitutes_Networks_Beacons/mcrc, name=Manchester Cancer Research Centre

Relation: https://research.manchester.ac.uk/en/publications/eb959c06-89d1-46b1-aa0f-dda1a7688dd4

الاتاحة: https://research.manchester.ac.uk/en/publications/eb959c06-89d1-46b1-aa0f-dda1a7688dd4
https://doi.org/10.1182/BLOODADVANCES.2020002553
http://www.scopus.com/inward/record.url?scp=85091496260&partnerID=8YFLogxK

المؤلفون: Zamecnikova, Adriana

المساهمون: Kuwait Cancer Control Center, Kuwait

مصطلحات موضوعية: AML, acute monoblastic leukemia, isochromosome 5p, clonal evolution, Leukaemia Section, Adult, Aged, Antineoplastic Agents, Alkylating/*adverse effects, Chromosome Aberrations, Chromosomes, Human, Pair 5/genetics, Pair 7/genetics, Cyclophosphamide/adverse effects/therapeutic use, Drug Therapy, Combination, Female, Follow-Up Studies, Humans, In Situ Hybridization, Fluorescence, Leukemia, Myeloid, Acute/*etiology/genetics/mortality/pathology, Male, Melphalan/adverse effects/therapeutic use, Middle Aged, Multiple Myeloma/*drug therapy/genetics, Myelodysplastic Syndromes/*etiology/genetics/mortality/pathology

Relation: Atlas of Genetics and Cytogenetics in Oncology and Haematology; http://AtlasGeneticsOncology.org/Anomalies/i05p10ID1825.html; Adriana, Zamecnikova. i(5)(p10) in hematological malignancies. Atlas of Genetics and Cytogenetics in Oncology and Haematology, 2019, 10, p. 304-306; http://hdl.handle.net/2042/70576; https://doi.org/10.4267/2042/70576

الاتاحة: http://hdl.handle.net/2042/70576
https://doi.org/10.4267/2042/70576

المؤلفون: Victoria, Corvest, Perrine, Marec-Bérard, Cyril, Lervat, Hélène, Pacquement, Maud, Toulmonde, Jean-Claude, Gentet, Valérie, Laurence, Morgane, Cleirec, Ludovic, Mansuy, Emmanuelle, Bompas, Marie-Pierre, Castex, Sophie, Taque, Bruno, Filhon, Marie-Dominique, Tabone, Cécile, Verité, Natacha, Entz-Werle, Laure, Saumet, Gregory, Guimard, Morgane, Pondrom, Christine, Chevreau, Jennifer, Flandrin, Lise, Duranteau, Christine, Rousset-Jablonski, Laurence, Brugières, Marta, Jimenez, Marie-Cécile, Le Deley, Nathalie, Gaspar, Brice, Fresneau

المساهمون: Institut Gustave Roussy (IGR), Centre Léon Bérard [Lyon], Institut d'hématologie et d'oncologie pédiatrique [CHU - HCL] (IHOPe), Hospices Civils de Lyon (HCL), Centre Régional de Lutte contre le Cancer Oscar Lambret [Lille] (UNICANCER/Lille), Université de Lille-UNICANCER, Institut Curie [Paris], Institut Bergonié [Bordeaux], UNICANCER, Hôpital de la Timone [CHU - APHM] (TIMONE), Centre hospitalier universitaire de Nantes (CHU Nantes), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), CRLCC René Gauducheau, Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), CHU Pontchaillou [Rennes], CHU Rouen, Normandie Université (NU), CHU Trousseau [APHP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Sorbonne Université (SU), Hôpital Pellegrin, CHU Bordeaux [Bordeaux]-Groupe hospitalier Pellegrin, CHU Strasbourg, Hôpital Arnaud de Villeneuve [CHRU Montpellier], Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Centre Hospitalier Universitaire de Reims (CHU Reims), Centre Hospitalier Universitaire de Nice (CHU Nice), Institut Claudius Regaud, Unité de Biostatistiques [Toulouse] ( Institut Claudius Regaud / IUCT-O), Institut Claudius Regaud-Institut Universitaire du Cancer de Toulouse - Oncopole (IUCT Oncopole - UMR 1037), Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Université de Toulouse (UT)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Université de Toulouse (UT)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Institut National de la Santé et de la Recherche Médicale (INSERM), Hôpital Bicêtre, Research on Healthcare Performance (RESHAPE - Inserm U1290 - UCBL1), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre de recherche en épidémiologie et santé des populations (CESP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay, Institut Gustave-Roussy, Centre Léon Bérard, CLB, Thanks to the investigators of the following French centers which contributed patients to our study: Centre Léon Bérard, medical oncology, Lyon, CHU St Etienne, CHU Clermont Ferrand, CHU Amiens, Regional Cancer Center, Nancy, Regional Cancer Center, Caen, CHU Besançon, Institut Gustave-Roussy, medical oncology, Villejuif, CHU Tours, CHU Marseille, CHU Grenoble, Regional Cancer Center, Dijon, Regional Cancer Center, Clermont Ferrand, Lenval Hospital, Nice, Regional Cancer Center, Angers, CHU Rouen.

المصدر: International Journal of Cancer
International Journal of Cancer, 2023, 152 (8), pp.1659-1667. ⟨10.1002/ijc.34326⟩

مصطلحات موضوعية: cyclophosphamide/adverse effects, child, Ewing/drug therapy, antineoplastic combined chemotherapy protocols/adverse effects, [SDV.CAN]Life Sciences [q-bio]/Cancer, Ifosfamide/adverse effects

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::7b644a71781b07ef0847fe0f23b11b80
https://hal.science/hal-04122360/document

المساهمون: College of Medicine, Dept. of Internal Medicine, Gun Min Kim, Sanghwa Kim, Hyung Seok Park, Jee Ye Kim, Sanggen Nam, Seho Park, Seung Il Kim, DoYoung Kim, Joohyuk Sohn, Kim, Gun Min, Kim, Do Young, Kim, Seung Il, Park, Se Ho, Park, Hyung Seok, Sohn, Joo Hyuk

مصطلحات موضوعية: Alopecia/chemically induced, Alopecia/epidemiology, Alopecia/pathology, Breast Neoplasms/complications, Breast Neoplasms/drug therapy, Breast Neoplasms/epidemiology, Breast Neoplasms/pathology, Bridged-Ring Compounds/administration & dosage, Bridged-Ring Compounds/adverse effects, Chemotherapy, Adjuvant/adverse effects, Cross-Sectional Studies, Cyclophosphamide/administration & dosage, Cyclophosphamide/adverse effects, Doxorubicin/administration & dosage, Doxorubicin/adverse effects, Drug-Related Side Effects and Adverse Reactions/pathology, Female, Humans, Neoplasm Staging, Taxoids/administration & dosage, Taxoids/adverse effects, Adverse reactions, Alopecia, Antineoplastic agents, Breast neopla�뒗, Drug-related side effects

Relation: BREAST CANCER RESEARCH AND TREATMENT; J00403; OAK-2017-02764; https://ir.ymlib.yonsei.ac.kr/handle/22282913/160210; https://link.springer.com/article/10.1007%2Fs10549-017-4204-x; T201701447; BREAST CANCER RESEARCH AND TREATMENT, Vol.163(3) : 527-533, 2017

الاتاحة: https://ir.ymlib.yonsei.ac.kr/handle/22282913/160210
https://doi.org/10.1007/s10549-017-4204-x
https://link.springer.com/article/10.1007%2Fs10549-017-4204-x

المؤلفون: Urs Schanz, Claire Seydoux, Nathan Cantoni, Patrick Simon, Stavroula Masouridi Levrat, Sabine Gerull, Joerg Halter, Michael Medinger, Yves Chalandon, Gayathri Nair, Dominik Heim, Marc Ansari, Jakob Passweg

المساهمون: University of Zurich, Medinger, Michael, Passweg, Jakob R

المصدر: Annals of Hematology
Annals of hematology, Vol. 100, No 1 (2021) pp. 209-216

مصطلحات موضوعية: Oncology, Male, 2720 Hematology, Hematologic Neoplasms / drug therapy, Cyclophosphamide / administration & dosage, law.invention, Transplantation Conditioning / methods, Randomized controlled trial, law, Transplantation Conditioning / mortality, Immunosuppressive Agents / administration & dosage, Prospective Studies, Transplantation, Homologous / methods, ddc:616, Busulfan / administration & dosage, Hematology, ddc:618, Hematopoietic cell transplantation, General Medicine, Middle Aged, Drug Therapy, Combination, Female, Original Article, medicine.drug, Hematopoietic Stem Cell Transplantation / mortality, Adult, medicine.medical_specialty, Cyclophosphamide, Liver toxicity, Immunosuppressive Agents / adverse effects, Chemical and Drug Induced Liver Injury / mortality, 610 Medicine & health, Animal data, Young Adult, Hematopoietic Stem Cell Transplantation / methods, Conditioning regimen, Internal medicine, medicine, Cyclophosphamide / adverse effects, Humans, Busulfan, Aged, Hematologic Neoplasms / mortality, Hematologic Neoplasms / therapy, Hematopoietic cell, business.industry, Retrospective cohort study, Chemical and Drug Induced Liver Injury / diagnosis, Transplantation, Homologous / mortality, Transplantation, 10032 Clinic for Oncology and Hematology, business, Busulfan / adverse effects

وصف الملف: Seydoux2021_Article_Busulfan-cyclophosphamideVersu.pdf - application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46778682dca6af300f13a48b5a897ccf
http://europepmc.org/articles/PMC7782401

المؤلفون: Nowakowski, Grzegorz S., Willenbacher, Wolfgang, Greil, Richard, Larsen, Thomas S., Patel, Krish, Jäger, Ulrich, Manges, Robert F., Trümper, Lorenz, Everaus, Hele, Kalakonda, Nagesh, Brown, Peter, Jørgensen, Judit Meszaros, Cunningham, David, Dell’Aringa, Justine, Fox, Brian, Rubio, Neus Domper, Kilavuz, Nurgul, Casadebaig, Marie Laure, Manzke, Oliver, Munoz, Javier

المصدر: Nowakowski , G S , Willenbacher , W , Greil , R , Larsen , T S , Patel , K , Jäger , U , Manges , R F , Trümper , L , Everaus , H , Kalakonda , N , Brown , P , Jørgensen , J M , Cunningham , D , Dell’Aringa , J , Fox , B , Rubio , N D , Kilavuz , N , Casadebaig , M L , Manzke , O & Munoz , J 2022 , ' Safety and efficacy of durvalumab with R-CHOP or R 2 -CHOP ....

مصطلحات موضوعية: Diffuse large B-cell lymphoma, Durvalumab, High risk, R-CHOP, Doxorubicin/adverse effects, Humans, Middle Aged, Male, Treatment Outcome, Antibodies, Monoclonal/adverse effects, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Prednisone/adverse effects, Disease-Free Survival, Lymphoma, Large B-Cell, Diffuse/drug therapy, Female, Aged, Cyclophosphamide/adverse effects, Vincristine/adverse effects, Rituximab/adverse effects

Relation: https://portal.findresearcher.sdu.dk/da/publications/a1eda3b7-edc6-42d6-9940-c2ac96b43009

الاتاحة: https://portal.findresearcher.sdu.dk/da/publications/a1eda3b7-edc6-42d6-9940-c2ac96b43009
https://doi.org/10.1007/s12185-021-03241-4

المؤلفون: Bachy, E., Camus, V., Thieblemont, C., Sibon, D., Casasnovas, R.O., Ysebaert, L., Damaj, G., Guidez, S., Pica, G.M., Kim, W.S., Lim, S.T., André, M., García-Sancho, A.M., Penarrubia, M.J., Staber, P.B., Trotman, J., Hüttmann, A., Stefoni, V., Re, A., Gaulard, P., Delfau-Larue, M.H., de Leval, L., Meignan, M., Li, J., Morschhauser, F., Delarue, R.

المصدر: Journal of clinical oncology, vol. 40, no. 3, pp. 242-251

مصطلحات موضوعية: Adult, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Asia, Australia, Cyclophosphamide/adverse effects, Cyclophosphamide/therapeutic use, Depsipeptides/adverse effects, Depsipeptides/therapeutic use, Disease Progression, Doxorubicin/adverse effects, Doxorubicin/therapeutic use, Europe, Female, Histone Deacetylase Inhibitors/adverse effects, Histone Deacetylase Inhibitors/therapeutic use, Humans, Lymphoma, T-Cell, Peripheral/drug therapy, Peripheral/mortality, Peripheral/pathology, Male, Middle Aged, Prednisone/adverse effects, Prednisone/therapeutic use, Progression-Free Survival, Time Factors

Relation: info:eu-repo/semantics/altIdentifier/pmid/34843406; info:eu-repo/semantics/altIdentifier/eissn/1527-7755; https://serval.unil.ch/notice/serval:BIB_176EB32E5BC5

الاتاحة: https://serval.unil.ch/notice/serval:BIB_176EB32E5BC5
https://doi.org/10.1200/JCO.21.01815